14-3-3 시그마 유전자 및/또는 단백질을 유효성분으로 포함하는 항염증용 조성물
    1.
    发明公开
    14-3-3 시그마 유전자 및/또는 단백질을 유효성분으로 포함하는 항염증용 조성물 有权
    包含14-3-3个SIGMA基因和蛋白质的抗炎组合物

    公开(公告)号:KR1020140102441A

    公开(公告)日:2014-08-22

    申请号:KR1020130015715

    申请日:2013-02-14

    CPC classification number: A61K48/00 A61K38/16 Y10S514/886

    Abstract: The present invention relates to an anti-inflammatory composition comprising 14-3-3 sigma gene and/or protein as an active ingredient. The 14-3-3 sigma gene is preferred to be composed of a base sequence of SEQ ID NO.1; and provided in the present invent is an anti-inflammatory composition comprising a 14-3-3 sigma protein as an active ingredient. In an embodiment of the present invention, the 14-3-3 sigma protein is preferred to be composed of a base sequence of SEQ ID NO. 2, but is not limited to the same; and provided in the present invention is an expression vector controlling inflammatory cytokine comprising the 14-3-3 sigma gene composed of SEQ ID NO.1 as an active ingredient.

    Abstract translation: 本发明涉及包含14-3-3σ基因和/或蛋白质作为活性成分的抗炎组合物。 14-3-3 sigma基因优选由SEQ ID NO.1的碱基序列组成; 并且在本发明中提供的是包含14-3-3σ蛋白作为活性成分的抗炎组合物。 在本发明的一个实施方案中,14-3-3σ蛋白质优选由SEQ ID NO.1的碱基序列组成。 2,但不限于此; 在本发明中提供了控制炎性细胞因子的表达载体,其包含由SEQ ID NO.1组成的14-3-3 sigma基因作为活性成分。

Patent Agency Ranking